Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics
| Autor: | Ma, Vincent T., Boonstra, Philip S., Menghrajani, Kamal, Perkins, Cecelia, Gowin, Krisstina L., Mesa, Ruben A., Gotlib, Jason R., Talpaz, Moshe |
|---|---|
| Zdroj: | In Clinical Lymphoma Myeloma and Leukemia May 2018 18(5):e201-e210 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect